- 74.6k views
Hepatitis B & C: Overview
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
About the Speaker
Dr. Uday Sanglodkar
Senior Consultant - Hepatology and Liver Transplant Global Hospital, Mumbai
About the Speaker Dr. Uday Sanglodkar is currently working as Senior Consultant - Hepatology and Liver Transplant Clinical Lead Liver intensive care. Dr Uday has worked at Rela Institute and Medical centre (RIMC) as a Consultant Hepatologist and Liver Transplant physician for 3 years. Dr Uday is a Senior Consultant with vast experience in hepatology/ transplant Hepatology. His areas of interest include Hepatobiliary diseases, liver intensive care and transplant Hepatology.
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Uday Sanglodkar 's Talks on Assimilate
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.